HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Specific macrophage subtypes influence the progression of rhabdomyolysis-induced kidney injury.

Abstract
Rhabdomyolysis can be life threatening if complicated by AKI. Macrophage infiltration has been observed in rat kidneys after glycerol-induced rhabdomyolysis, but the role of macrophages in rhabdomyolysis-induced AKI remains unknown. Here, in a patient diagnosed with rhabdomyolysis, we detected substantial macrophage infiltration in the kidney. In a mouse model of rhabdomyolysis-induced AKI, diverse renal macrophage phenotypes were observed depending on the stage of the disease. Two days after rhabdomyolysis, F4/80(low)CD11b(high)Ly6b(high)CD206(low) kidney macrophages were dominant, whereas by day 8, F4/80(high)CD11b(+)Ly6b(low)CD206(high) cells became the most abundant. Single-cell gene expression analyses of FACS-sorted macrophages revealed that these subpopulations were heterogeneous and that individual cells simultaneously expressed both M1 and M2 markers. Liposomal clodronate-mediated macrophage depletion significantly reduced the early infiltration of F4/80(low)CD11b(high)Ly6b(high)CD206(low) macrophages. Furthermore, transcriptionally regulated targets potentially involved in disease progression, including fibronectin, collagen III, and chemoattractants that were identified via single-cell analysis, were verified as macrophage-dependent in situ. In vitro, myoglobin treatment induced proximal tubular cells to secrete chemoattractants and macrophages to express proinflammatory markers. At day 30, liposomal clodronate-mediated macrophage depletion reduced fibrosis and improved both kidney repair and mouse survival. Seven months after rhabdomyolysis, histologic lesions were still present but were substantially reduced with prior depletion of macrophages. These results suggest an important role for macrophages in rhabdomyolysis-induced AKI progression and advocate the utility of long-term follow-up for patients with this disease.
AuthorsJulie Belliere, Audrey Casemayou, Laure Ducasse, Alexia Zakaroff-Girard, Frédéric Martins, Jason S Iacovoni, Céline Guilbeau-Frugier, Bénédicte Buffin-Meyer, Bernard Pipy, Dominique Chauveau, Joost P Schanstra, Jean-Loup Bascands
JournalJournal of the American Society of Nephrology : JASN (J Am Soc Nephrol) Vol. 26 Issue 6 Pg. 1363-77 (Jun 2015) ISSN: 1533-3450 [Electronic] United States
PMID25270069 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 by the American Society of Nephrology.
Chemical References
  • Myoglobin
  • Clodronic Acid
  • Glycerol
Topics
  • Acute Kidney Injury (etiology, physiopathology)
  • Animals
  • Cells, Cultured
  • Clodronic Acid (pharmacology)
  • Disease Models, Animal
  • Disease Progression
  • Flow Cytometry
  • Glycerol (pharmacology)
  • Humans
  • Macrophages (classification, metabolism, pathology)
  • Male
  • Mice
  • Myoglobin (drug effects, metabolism)
  • Random Allocation
  • Rhabdomyolysis (complications, physiopathology)
  • Risk Factors
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: